TTrialPathMatch Me to Trials
← Back to trials
RecruitingKidney Transplant; ComplicationsDiabetes Mellitus, Type 2Insulin Dependent Diabetes

Use of CGM in Kidney Transplant Recipients

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.

Sponsor: University of California, Davis

You may qualify if…

  • ✓ 1. Age 18 or above
  • ✓ 2. Received a kidney transplant within the past year with functioning kidney (eGFR \> 30 mL/min
  • ✓ 3. Person with Type 2 Diabetes and on insulin
  • ✓ 4. Access to home wi-fi connection

You may not qualify if…

  • ✕ 1. Person with Type 1 Diabetes
  • ✕ 2. Patients taking hydroxyurea
  • ✕ 3. Patient unable to wear the Dexcom G6 device at all times for any reason
  • ✕ 4. Must be able to test blood glucose with meter 4x a day when on blinded CGM.
  • ✕ 5. Presence of clinically significant visual or cognitive impairment
  • ✕ 6. Illiterate
  • ✕ 7. Prisoners
  • ✕ 8. Women who are pregnant, who plan to become pregnant during the course of the study, or who are breastfeeding

Where it's recruiting

California

Sacramento

Source: ClinicalTrials.gov · NCT04783441 · last updated 2026-01-29

Use of CGM in Kidney Transplant Recipients · TrialPath